Titre : ATP-dependent proteases

ATP-dependent proteases : Questions médicales fréquentes

Termes MeSH sélectionnés :

Astigmatism
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "ATP-dependent proteases : Questions médicales les plus fréquentes", "headline": "ATP-dependent proteases : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les ATP-dependent proteases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-23", "dateModified": "2025-02-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "ATP-dependent proteases" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "ATPases associated with diverse cellular activities", "url": "https://questionsmedicales.fr/mesh/D000074183", "about": { "@type": "MedicalCondition", "name": "ATPases associated with diverse cellular activities", "code": { "@type": "MedicalCode", "code": "D000074183", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.157.025.750" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "ATP-dependent endopeptidases", "alternateName": "ATP-Dependent Endopeptidases", "url": "https://questionsmedicales.fr/mesh/D057065", "about": { "@type": "MedicalCondition", "name": "ATP-dependent endopeptidases", "code": { "@type": "MedicalCode", "code": "D057065", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.157.025.750.032.099" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Protease La", "alternateName": "Protease La", "url": "https://questionsmedicales.fr/mesh/D049070", "about": { "@type": "MedicalCondition", "name": "Protease La", "code": { "@type": "MedicalCode", "code": "D049070", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.157.025.750.032.099.750" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "ATP-dependent proteases", "alternateName": "ATP-Dependent Proteases", "code": { "@type": "MedicalCode", "code": "D049069", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Zhou Sha", "url": "https://questionsmedicales.fr/author/Zhou%20Sha", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Case Western Reserve University, Cleveland, Ohio, 44106, USA." } }, { "@type": "Person", "name": "Jennifer Fishovitz", "url": "https://questionsmedicales.fr/author/Jennifer%20Fishovitz", "affiliation": { "@type": "Organization", "name": "Department of Chemistry and Physics, Saint Mary's College, Notre Dame, Indiana, 46556, USA." } }, { "@type": "Person", "name": "Sujatha Chilakala", "url": "https://questionsmedicales.fr/author/Sujatha%20Chilakala", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Cleveland State University, Cleveland, Ohio, 44115, USA." } }, { "@type": "Person", "name": "Yan Xu", "url": "https://questionsmedicales.fr/author/Yan%20Xu", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Cleveland State University, Cleveland, Ohio, 44115, USA." } }, { "@type": "Person", "name": "Irene Lee", "url": "https://questionsmedicales.fr/author/Irene%20Lee", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Case Western Reserve University, Cleveland, Ohio, 44106, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "SmartSight Correction of Compound Myopic Astigmatism Treatments With Preoperative Astigmatism > 1.00 Diopter Using the SCHWIND ATOS: A Retrospective Case Series.", "datePublished": "2024-05-01", "url": "https://questionsmedicales.fr/article/38717080", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3928/1081597X-20240415-02" } }, { "@type": "ScholarlyArticle", "name": "The Prevalence of Astigmatism and Spectacle Wear in Polish Schoolchildren.", "datePublished": "2023-08-01", "url": "https://questionsmedicales.fr/article/37526941", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": null } }, { "@type": "ScholarlyArticle", "name": "Epidemiology and Burden of Astigmatism: A Systematic Literature Review.", "datePublished": "2023-02-07", "url": "https://questionsmedicales.fr/article/36749017", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/OPX.0000000000001998" } }, { "@type": "ScholarlyArticle", "name": "Astigmatism Profile in a Large Series of Brazilian Patients.", "datePublished": "2023-01-01", "url": "https://questionsmedicales.fr/article/36630436", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3928/1081597X-20221122-01" } }, { "@type": "ScholarlyArticle", "name": "Clinical results of topography-guided laser-assisted in situ keratomileusis using the anterior corneal astigmatism axis and manifest refractive astigmatism axis.", "datePublished": "2022-07-27", "url": "https://questionsmedicales.fr/article/35895108", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00417-022-05775-7" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines de transport", "item": "https://questionsmedicales.fr/mesh/D002352" }, { "@type": "ListItem", "position": 5, "name": "Protéines AAA", "item": "https://questionsmedicales.fr/mesh/D000074582" }, { "@type": "ListItem", "position": 6, "name": "ATPases associated with diverse cellular activities", "item": "https://questionsmedicales.fr/mesh/D000074183" }, { "@type": "ListItem", "position": 7, "name": "ATP-dependent proteases", "item": "https://questionsmedicales.fr/mesh/D049069" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : ATP-dependent proteases - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur ATP-dependent proteases", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur ATP-dependent proteases", "description": "Comment diagnostiquer une dysfonction des protéases ATP-dépendantes ?\nQuels tests sanguins sont utiles pour évaluer ces protéases ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes peuvent indiquer un problème avec ces enzymes ?\nPeut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux protéases ?", "url": "https://questionsmedicales.fr/mesh/D049069?mesh_terms=Astigmatism&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur ATP-dependent proteases", "description": "Quels sont les symptômes d'une déficience en protéases ATP-dépendantes ?\nLes troubles neurologiques sont-ils liés à ces protéases ?\nComment la dégradation des protéines affecte-t-elle la santé ?\nY a-t-il des signes cutanés associés à ces troubles ?\nLes douleurs musculaires peuvent-elles être un symptôme ?", "url": "https://questionsmedicales.fr/mesh/D049069?mesh_terms=Astigmatism&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur ATP-dependent proteases", "description": "Comment prévenir les troubles liés aux protéases ?\nL'exercice physique joue-t-il un rôle préventif ?\nLes contrôles médicaux réguliers sont-ils importants ?\nY a-t-il des vaccins pour prévenir ces troubles ?\nLe stress peut-il affecter la fonction des protéases ?", "url": "https://questionsmedicales.fr/mesh/D049069?mesh_terms=Astigmatism&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur ATP-dependent proteases", "description": "Quels traitements existent pour les troubles liés aux protéases ?\nLes suppléments alimentaires peuvent-ils aider ?\nLa thérapie génique est-elle une option ?\nLes médicaments anti-inflammatoires sont-ils utiles ?\nComment la physiothérapie peut-elle aider ?", "url": "https://questionsmedicales.fr/mesh/D049069?mesh_terms=Astigmatism&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur ATP-dependent proteases", "description": "Quelles complications peuvent survenir avec des troubles protéolytiques ?\nLes complications cardiovasculaires sont-elles possibles ?\nComment les troubles protéolytiques affectent-ils le système immunitaire ?\nY a-t-il un risque accru de cancer ?\nLes troubles neurologiques peuvent-ils s'aggraver ?", "url": "https://questionsmedicales.fr/mesh/D049069?mesh_terms=Astigmatism&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur ATP-dependent proteases", "description": "Quels sont les facteurs de risque pour les troubles protéolytiques ?\nLe mode de vie influence-t-il ces risques ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nLe stress chronique est-il un facteur de risque ?\nL'exposition à des toxines peut-elle augmenter le risque ?", "url": "https://questionsmedicales.fr/mesh/D049069?mesh_terms=Astigmatism&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction des protéases ATP-dépendantes ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques et des analyses protéomiques peuvent être utilisés." } }, { "@type": "Question", "name": "Quels tests sanguins sont utiles pour évaluer ces protéases ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des dosages d'enzymes spécifiques et des marqueurs de dégradation protéique sont recommandés." } }, { "@type": "Question", "name": "Les biopsies sont-elles nécessaires pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des biopsies peuvent aider à évaluer l'activité des protéases dans les tissus." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec ces enzymes ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fatigue, la perte de poids et des troubles métaboliques peuvent survenir." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux protéases ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie peut aider à visualiser des anomalies tissulaires, mais pas directement les protéases." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en protéases ATP-dépendantes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, troubles digestifs, et accumulation de protéines mal repliées peuvent se manifester." } }, { "@type": "Question", "name": "Les troubles neurologiques sont-ils liés à ces protéases ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dysfonctionnements peuvent entraîner des troubles neurologiques et cognitifs." } }, { "@type": "Question", "name": "Comment la dégradation des protéines affecte-t-elle la santé ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une dégradation inappropriée peut mener à des maladies dégénératives et à l'inflammation." } }, { "@type": "Question", "name": "Y a-t-il des signes cutanés associés à ces troubles ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées et des problèmes de cicatrisation peuvent être observés." } }, { "@type": "Question", "name": "Les douleurs musculaires peuvent-elles être un symptôme ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs musculaires peuvent survenir en raison d'une dégradation protéique anormale." } }, { "@type": "Question", "name": "Comment prévenir les troubles liés aux protéases ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à maintenir leur fonction." } }, { "@type": "Question", "name": "L'exercice physique joue-t-il un rôle préventif ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la santé musculaire et enzymatique." } }, { "@type": "Question", "name": "Les contrôles médicaux réguliers sont-ils importants ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des bilans réguliers peuvent détecter précocement des anomalies protéolytiques." } }, { "@type": "Question", "name": "Y a-t-il des vaccins pour prévenir ces troubles ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccins spécifiques pour ces troubles enzymatiques." } }, { "@type": "Question", "name": "Le stress peut-il affecter la fonction des protéases ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut perturber l'équilibre enzymatique et la santé cellulaire." } }, { "@type": "Question", "name": "Quels traitements existent pour les troubles liés aux protéases ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies enzymatiques et des médicaments ciblant les voies protéolytiques sont utilisés." } }, { "@type": "Question", "name": "Les suppléments alimentaires peuvent-ils aider ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains suppléments peuvent soutenir la fonction protéolytique et la santé cellulaire." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est explorée pour corriger des déficiences enzymatiques spécifiques." } }, { "@type": "Question", "name": "Les médicaments anti-inflammatoires sont-ils utiles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent réduire l'inflammation causée par une dégradation protéique anormale." } }, { "@type": "Question", "name": "Comment la physiothérapie peut-elle aider ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La physiothérapie peut améliorer la fonction musculaire et réduire la douleur associée." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des troubles protéolytiques ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des maladies dégénératives, des troubles métaboliques et des infections peuvent survenir." } }, { "@type": "Question", "name": "Les complications cardiovasculaires sont-elles possibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déséquilibres protéolytiques peuvent contribuer à des maladies cardiovasculaires." } }, { "@type": "Question", "name": "Comment les troubles protéolytiques affectent-ils le système immunitaire ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent affaiblir le système immunitaire, rendant l'organisme plus vulnérable aux infections." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de cancer ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans la dégradation des protéines peuvent être liées à certains cancers." } }, { "@type": "Question", "name": "Les troubles neurologiques peuvent-ils s'aggraver ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles protéolytiques non traités peuvent aggraver les symptômes neurologiques." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles protéolytiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, des antécédents familiaux et des maladies métaboliques augmentent le risque." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il ces risques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent les risques." } }, { "@type": "Question", "name": "Les maladies auto-immunes sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent perturber la fonction des protéases et entraîner des complications." } }, { "@type": "Question", "name": "Le stress chronique est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter la régulation des protéases et la santé globale." } }, { "@type": "Question", "name": "L'exposition à des toxines peut-elle augmenter le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines toxines peuvent altérer la fonction des protéases et causer des dommages cellulaires." } } ] } ] }

Sources (445 au total)

SmartSight Correction of Compound Myopic Astigmatism Treatments With Preoperative Astigmatism > 1.00 Diopter Using the SCHWIND ATOS: A Retrospective Case Series.

To evaluate moderate to high astigmatism corrections on the outcomes of SmartSight lenticule extraction for myopic astigmatism with a new femtosecond laser system.... Two hundred ninety-two eyes consecutively treated for myopic astigmatism with astigmatism magnitude greater than 1.00 diopter (D) were evaluated at the 6-month follow-up visit. The mean age of the pat... At 6 months, astigmatism was 0.10 ± 0.20 D. Uncorrected and corrected distance visual acuities (UDVA and CDVA, respectively) were both 0.0 ± 0.1 logMAR. Differences between postoperative UDVA and preo... Lenticule extraction treatment using Smart-Sight is safe and efficacious at 6 months. Findings suggest that moderate to high astigmatism improves after SmartSight lenticule extraction in the treatment...

The Prevalence of Astigmatism and Spectacle Wear in Polish Schoolchildren.

Unilateral or asymmetric astigmatism is considered a principal refractive error leading to amblyopia and regular eye examinations should be carried out during childhood to prevent visual impairment. T... A cross sectional study was carried out in children aged 6 to 14 years old from 50 schools in Poland. The presence of astigmatism was assessed by non-cycloplegic autorefraction, and defined as a cylin... The study included 1041 children and 52.3% were girls (... This study reports a low prevalence of astigmatism in Polish school children. However, the majority of children with astigmatism were uncorrected. Further longitudinal studies are warranted....

Epidemiology and Burden of Astigmatism: A Systematic Literature Review.

This is the first literature review to report the epidemiology, patient burden, and economic burden of astigmatism in the general adult population. The unmet needs of astigmatism patients with coexist... This study aimed to identify, report, and summarize the published literature on epidemiology, patient burden, and economic burden of astigmatism using a systematic literature review.... MEDLINE, EMBASE, and Cochrane Library databases were searched (January 1996 to May 2021). Search results were limited to the English language. Proceedings (2018 to 2021) from ophthalmology congresses ... The literature search yielded 6804 citations, of which 125 met the inclusion criteria (epidemiology, 68; patient burden, 60; economic burden, 6). Astigmatism prevalence in the general population varie... Uncorrected astigmatism decreases patients' vision-related quality of life, decreases productivity among working-age adults, and poses an economic burden on patients and their families....

Astigmatism Profile in a Large Series of Brazilian Patients.

To assess anterior, posterior, and total corneal astigmatism in a large sample of Brazilian patients.... In this retrospective cross-sectional study, all patients whose corneas were imaged with the Galilei G6 (Ziemer Ophthalmology) between January 2017 and February 2019 at HOPE Eye Hospital, in Recife, B... The study included 3,253 eyes of 1,919 patients. The mean magnitude of the anterior, posterior, and total corneal astigmatism was 1.50 ± 1.11, 0.34 ± 0.15, and 1.29 ± 0.98 diopters (D), respectively. ... Corneal astigmatism values in the Brazilian population were similar to those found in other ethnicities, suggesting that toric calculators, nomograms, coefficients of adjustment, and formulas that wer...

Clinical results of topography-guided laser-assisted in situ keratomileusis using the anterior corneal astigmatism axis and manifest refractive astigmatism axis.

To evaluate the clinical results of primary topography-guided femtosecond laser-assisted in situ keratomileusis (TG-FS-LASIK) using the Pentacam-measured anterior corneal astigmatism axis (ACA) or man... In this prospective cohort study, all eyes were treated with primary TG-FS-LASIK using the manifest cylinder. Thirty-two right eyes were treated using ACA with axis disparity > 5° in the experimental ... The mean logMAR UDVA in the experimental group was - 0.12 ± 0.06, - 0.05 ± 0.08, and - 0.08 ± 0.08 at 1-week, 1-month, and 3-month follow-up, whereas - 0.05 ± 0.06, - 0.12 ± 0.06, and - 0.14 ± 0.06 in... Primary topography-guided FS-LASIK using Pentacam-measured anterior corneal astigmatism axis exhibited slightly inferior clinical results to that using the manifest refractive astigmatism axis. Both m...

Comparison of Total Corneal Astigmatism between IOLMaster and Pentacam.

To compare the total corneal astigmatism (TCA) measured by IOLMaster 700 and Pentacam and to investigate the consistency of corneal keratometry (CK) measured by IOLMaster and Pentacam.... Cataract patients were retrospectively enrolled in March and April, 2021. Retrospective analysis was performed on those patients with binocular and monocular CK measured by IOLMaster and Pentacam.... A total of 102 patients (204 eyes) were included, 64 of whom were female (62.75%). The flat (K1) and steep (K2) CK of anterior corneal surface (ACS) and flat (TK1) and steep (TK2) of total cornea meas... Total corneal astigmatism measured by IOLMaster was consistent with that measured by Pentacam. The difference between the astigmatism of anterior corneal surface and total cornea was detected in the m...

Intraocular lens power calculation in patients with irregular astigmatism.

Accurate intraocular lens (IOL) calculation in subjects with irregular astigmatism is challenging. This study evaluated the accuracy of using Scheimpflug-derived central 2-mm equivalent keratometry re... This retrospective study included subjects (31 eyes of 30 patients) who underwent cataract surgery and IOL calculation using the 2-mm central EKR methods. We compared prediction error (PE) and absolut... Cataract surgery and IOL calculation using the 2-mm central EKR methods resulted in improved visual acuity (uncorrected: from 1.13 ± 0.38 to 0.65 ± 0.46 logMar, p < 0.01; best-corrected: from 0.45 ± 0... The use of Scheimpflug central 2-mm EKR for IOL calculation in irregular astigmatism was beneficial in terms of visual acuity improvement. It had comparable refractive prediction performance to the IO...

Surgically Induced Astigmatism after Cataract Surgery - A Vector Analysis.

Surgically induced astigmatism (SIA) has been widely discussed in the literature as the change in corneal astigmatism resulting from corneal incision. The purpose of this study was to investigate the ... The analysis was based on a dataset of 122 eyes of 122 patients with preoperative and one month postoperative measurements performed with the IOLMaster 700 biometer from 1 clinical center and a standa... The mean corneal power of total keratometry reduced slightly after cataract surgery (-0.05 dpt), resulting mostly from a decrease in back surface power (-0.04 dpt). The astigmatism vector component C... Cataract surgery locally flattens the cornea in the incision meridian. This flattening shows a large individual variation and therefore a poor predictability. Our study indicates that SIA in modern ca...

Astigmatism profile in the elderly population: Tehran Geriatric Eye Study.

To determine the prevalence of astigmatism and its associated factors and examine astigmatism symmetry patterns in an elderly population.... Population based cross-sectional study.... The present population-based cross-sectional study was conducted on an elderly population above 60 years of age in Tehran, Iran in 2019. The sampling was done using the stratified multistage random cl... The prevalence of astigmatism higher than -0.50, -1.00, and -2.00 D was 83% (95% CI: 81 -84), 52 % (95% CI: 50 -54), and 19% (95% CI: 17-20), respectively. These prevalence was 79%(95% CI: 77-81), 46(... The prevalence of astigmatism was high in the elderly population of Tehran. More than half of the participants in this study had anisorule astigmatism, and against the rule-oblique combination was mor...